Heron Therapeutics
HRTX
#10089
Rank
โ‚ฌ62.66 M
Marketcap
0,33ย โ‚ฌ
Share price
26.48%
Change (1 day)
-65.67%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -1,12ย โ‚ฌ

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -0,17ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,54ย โ‚ฌ an increase over its 2021 EPS that were of -2,00ย โ‚ฌ.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,12ย โ‚ฌ-27.57%
2022-1,54ย โ‚ฌ-23.11%
2021-2,00ย โ‚ฌ-10%
2020-2,23ย โ‚ฌ-0%
2019-2,23ย โ‚ฌ1.21%
2018-2,20ย โ‚ฌ-32.7%
2017-3,27ย โ‚ฌ-19.34%
2016-4,05ย โ‚ฌ54.76%
2015-2,62ย โ‚ฌ1.73%
2014-2,57ย โ‚ฌ-16.23%
2013-3,07ย โ‚ฌ91.67%
2012-1,60ย โ‚ฌ-31.45%
2011-2,34ย โ‚ฌ-27.06%
2010-3,21ย โ‚ฌ-43.75%
2009-5,70ย โ‚ฌ-57.33%
2008-13,36ย โ‚ฌ-82.92%
2007-78,21ย โ‚ฌ20.61%
2006-64,84ย โ‚ฌ175.76%
2005-23,51ย โ‚ฌ-21.43%
2004-29,93ย โ‚ฌ100%
2003-14,96ย โ‚ฌ-38.24%
2002-24,23ย โ‚ฌ161.54%
2001-9,26ย โ‚ฌ-106.46%
2000143,31ย โ‚ฌ2174.12%
19996,30ย โ‚ฌ839.73%
19980,67ย โ‚ฌ-105.48%
1997-12,25ย โ‚ฌ-88.16%
1996-103,44ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-1,10ย โ‚ฌ 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
0,31ย โ‚ฌ-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
8,92ย โ‚ฌ-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
0,36ย โ‚ฌ-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-2,64ย โ‚ฌ 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA